Treatment of hyponatraemia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) should be guided by the symptomatology of the patient, which can be used as a surrogate for the duration of the hyponatraemia. However, in patients with acute symptomatic hyponatraemia (developing in <48 hours), the need to actively treat hyponatraemia is more imperative due to the potential risks associated with leaving hyponatraemia untreated (including the potential for development of serious neurological manifestations, such as seizures and brain stem herniation). In patients with hyponatraemia care needs to be taken not to exceed the recommended rates of correction, as this increases the risk of osmotic demyelination syndrome. This article will discuss the potential impact of prompt intervention in the treatment of hyponatraemia, particularly secondary to SIADH, and the need to weigh the benefits of treatment against the potential risks associated with overly rapid correction. © 2012 Elsevier Ltd. All rights reserved.

Considerations regarding the management of hyponatraemia secondary to SIADH / A. Peri; C. Combe. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1521-690X. - STAMPA. - 26 suppl 1:(2012), pp. S16-S26.

Considerations regarding the management of hyponatraemia secondary to SIADH

PERI, ALESSANDRO;
2012

Abstract

Treatment of hyponatraemia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) should be guided by the symptomatology of the patient, which can be used as a surrogate for the duration of the hyponatraemia. However, in patients with acute symptomatic hyponatraemia (developing in <48 hours), the need to actively treat hyponatraemia is more imperative due to the potential risks associated with leaving hyponatraemia untreated (including the potential for development of serious neurological manifestations, such as seizures and brain stem herniation). In patients with hyponatraemia care needs to be taken not to exceed the recommended rates of correction, as this increases the risk of osmotic demyelination syndrome. This article will discuss the potential impact of prompt intervention in the treatment of hyponatraemia, particularly secondary to SIADH, and the need to weigh the benefits of treatment against the potential risks associated with overly rapid correction. © 2012 Elsevier Ltd. All rights reserved.
2012
26 suppl 1
S16
S26
A. Peri; C. Combe
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1521690X12700040-main.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 170.83 kB
Formato Adobe PDF
170.83 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/629094
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact